{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:27:36Z","timestamp":1792524456004,"version":"4.5.0"},"reference-count":45,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"EU Commission","award":["JUST\/2011\/DPIP\/AG\/3597"],"award-info":[{"award-number":["JUST\/2011\/DPIP\/AG\/3597"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hum. Psychopharmacol Clin Exp"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1002\/hup.2512","type":"journal-article","created":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T04:00:49Z","timestamp":1452744049000},"page":"44-52","source":"Crossref","is-referenced-by-count":51,"title":["New psychoactive substances as part of polydrug abuse within opioid maintenance treatment revealed by comprehensive high-resolution mass spectrometric urine drug screening"],"prefix":"10.1002","volume":"31","author":[{"given":"Pertti","family":"Heikman","sequence":"first","affiliation":[{"name":"Department of Psychiatry; University of Helsinki; Helsinki Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Sundstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine; University of Helsinki; Helsinki Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pelander","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine; University of Helsinki; Helsinki Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilkka","family":"Ojanper\u00e4","sequence":"additional","affiliation":[{"name":"Department of Forensic Medicine; University of Helsinki; Helsinki Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,1,13]]},"reference":[{"key":"10.1002\/hup.2512-BIB0001|hup2512-cit-0001","first-page":"290365","article-title":"Acute psychotic symptoms due to benzydamine hydrochloride abuse with alcohol","volume":"2014","author":"Acar","year":"2014","journal-title":"Case Rep Psychiatry"},{"key":"10.1002\/hup.2512-BIB0002|hup2512-cit-0002","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3109\/15563650.2014.974262","article-title":"Cardiogenic shock after use of fluoroamphetamine confirmed with serum and urine levels","volume":"52","author":"Al-Abri","year":"2014","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1002\/hup.2512-BIB0003|hup2512-cit-0003","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1055\/s-0032-1330033","article-title":"Safety, effectiveness and tolerance of buprenorphine-naloxone in the treatment of opioid dependence: results from a nationwide non-interventional study in routine care","volume":"46","author":"Apelt","year":"2013","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/hup.2512-BIB0004|hup2512-cit-0004","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/09595230601052777","article-title":"Zopiclone misuse: an update from Dublin","volume":"26","author":"Bannan","year":"2007","journal-title":"Drug Alcohol Rev"},{"key":"10.1002\/hup.2512-BIB0005|hup2512-cit-0005","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/dta.1577","article-title":"Dextrometrophan\/levomethorphan issues in a case of opiate overdose","volume":"5","author":"Bortolotti","year":"2013","journal-title":"Drug Test Anal"},{"key":"10.1002\/hup.2512-BIB0006|hup2512-cit-0006","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/hup.2299","article-title":"Promoting innovation and excellence to face the rapid diffusion of novel psychoactive substances in the EU: the outcomes of ReDNet project","volume":"28","author":"Corazza","year":"2013","journal-title":"Hum Psychopharmacol Clin Exp Special Issue on Novel Psychoactive substances"},{"key":"10.1002\/hup.2512-BIB0007|hup2512-cit-0007","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/hup.2222","article-title":"Phenazepam abuse in the UK: an emerging problem causing serious adverse health problems, including death","volume":"27","author":"Corkery","year":"2012","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"10.1002\/hup.2512-BIB0008|hup2512-cit-0008","unstructured":"EMCDDA 2015a European Drug Report http:\/\/www.emcdda.europa.eu\/edr2015 st"},{"key":"10.1002\/hup.2512-BIB0009|hup2512-cit-0009","unstructured":"EMCDDA 2015b National report 2014: Finland, Drug Situation 2014 http:\/\/www.emcdda.europa.eu\/publications\/national-reports\/finland-2014 st"},{"key":"10.1002\/hup.2512-BIB0010|hup2512-cit-0010","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1017\/S1461145713001600","article-title":"Abuse liability of centrally acting non-opioid analgesics and muscle relaxants-a brief update based on a comparison of pharmacovigilance data and evidence from the literature","volume":"17","author":"Gahr","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1002\/hup.2512-BIB0011|hup2512-cit-0011","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/hup.2323","article-title":"Consumption of new psychoactive substances in a Spanish sample of research chemical users","volume":"28","author":"Gonzalez","year":"2013","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"10.1002\/hup.2512-BIB0012|hup2512-cit-0012","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1007\/s00228-013-1578-5","article-title":"Pregabalin abuse among opiate addicted patients","volume":"69","author":"Grosshans","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1002\/hup.2512-BIB0013|hup2512-cit-0013","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.drugalcdep.2014.11.033","article-title":"Monitoring new psychoactive substances (NPS) in the Netherlands: data from the drug market and the Poisons Information Centre","volume":"147","author":"Hondebrink","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1002\/hup.2512-BIB0014|hup2512-cit-0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2131\/jts.39.1","article-title":"New recreational drug 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (alpha-PVP) activates central nervous system via dopaminergic neuron","volume":"39","author":"Kaizaki","year":"2014","journal-title":"J Toxicol Sci"},{"key":"10.1002\/hup.2512-BIB0015|hup2512-cit-0015","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.forsciint.2011.03.018","article-title":"Desorption atmospheric pressure photoionization-mass spectrometry in routine analysis of confiscated drugs","volume":"210","author":"Kauppila","year":"2011","journal-title":"Forensic Sci Int"},{"key":"10.1002\/hup.2512-BIB0016|hup2512-cit-0016","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00414-015-1184-4","article-title":"The effect of banning MDPV on the incidence of MDPV-positive findings among users of illegal drugs and on court decisions in traffic cases in Finland","volume":"129","author":"Kriikku","year":"2015","journal-title":"Int J Legal Med"},{"key":"10.1002\/hup.2512-BIB0017|hup2512-cit-0017","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s13181-014-0399-y","article-title":"Acute toxicity associated with analytically confirmed recreational use of methiopropamine (1-(thiophen-2-yl)-2-methylaminopropane)","volume":"10","author":"Lee","year":"2014","journal-title":"J Med Toxicol"},{"key":"10.1002\/hup.2512-BIB0018|hup2512-cit-0018","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.forsciint.2013.08.021","article-title":"The analytical investigation of synthetic street drugs containing cathinone analogs","volume":"234","author":"Leffler","year":"2014","journal-title":"Forensic Sci Int"},{"key":"10.1002\/hup.2512-BIB0019|hup2512-cit-0019","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.drugalcdep.2010.12.007","article-title":"Multiple substance use among heroin-dependent patients before and during attendance at methadone maintenance treatment program, Tunnan, China","volume":"116","author":"Li","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"10.1002\/hup.2512-BIB0020|hup2512-cit-0020","first-page":"303","article-title":"The research for polydrug abuse among one hundred and sixty nine community-based methadone maintenance treatment patients","volume":"22","author":"Liu","year":"2013","journal-title":"Chin J Drug Depend"},{"key":"10.1002\/hup.2512-BIB0021|hup2512-cit-0021","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jat\/bks136","article-title":"Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results","volume":"37","author":"Marinetti","year":"2013","journal-title":"J Anal Toxicol"},{"key":"10.1002\/hup.2512-BIB0022|hup2512-cit-0022","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neuropharm.2014.02.016","article-title":"Pharmacology of novel synthetic stimulants structurally related to the \u201cbath salts\u201d constituent 3,4-methylenedioxypyrovalerone (MDPV)","volume":"87","author":"Marusich","year":"2014","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1002\/hup.2512-BIB0023|hup2512-cit-0023","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub4","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1002\/hup.2512-BIB0024|hup2512-cit-0024","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.drugpo.2014.10.010","article-title":"Mortality related to novel psychoactive substances in Scotland, 2012: an exploratory study","volume":"26","author":"McAuley","year":"2015","journal-title":"Int J Drug Pol"},{"key":"10.1002\/hup.2512-BIB0025|hup2512-cit-0025","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/JCP.0b013e3182670648","article-title":"Characteristics of quetiapine misuse among clients of a community-based methadone maintenance program","volume":"32","author":"McLarnon","year":"2012","journal-title":"J Clin Psychopharmacol"},{"key":"10.1002\/hup.2512-BIB0026|hup2512-cit-0026","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/phar.1424","article-title":"Review of therapeutics \u201cnot for human consumption\u201d: a review of emerging designer drugs","volume":"34","author":"Musselman","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1002\/hup.2512-BIB0027|hup2512-cit-0027","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijcard.2013.12.262","article-title":"Sudden death after sustained restraint following self-administration of the designer drug \u03b1-pyrrolidinovalerophenone","volume":"172","author":"Nagai","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1002\/hup.2512-BIB0028|hup2512-cit-0028","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/FTD.0b013e318208b693","article-title":"Urine analysis of 3,4-methylenedioxypyrovalerone in opioid-dependent patients by gas chromatography-mass spectrometry","volume":"33","author":"Ojanper\u00e4","year":"2011","journal-title":"Ther Drug Monit"},{"key":"10.1002\/hup.2512-BIB0029|hup2512-cit-0029","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/ADM.0000000000000044","article-title":"Intravenous administration and abuse of bupropion: a case report and a review of the literature","volume":"8","author":"Oppek","year":"2014","journal-title":"J Addict Med"},{"key":"10.1002\/hup.2512-BIB0030|hup2512-cit-0030","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/hup.2466","article-title":"Profiling online recreational\/prescription drugs' customers and overview of drug vending virtual marketplaces","volume":"30","author":"Orsolini","year":"2015","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"10.1002\/hup.2512-BIB0031|hup2512-cit-0031","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00228-014-1783-x","article-title":"Detection of signals of abuse and dependence applying disproportionality analysis","volume":"71","author":"Pauly","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1002\/hup.2512-BIB0032|hup2512-cit-0032","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/01.yic.0000166404.41850.b4","article-title":"Dependence on zolpidem: two case reports of detoxification with flumazenil infusion","volume":"20","author":"Quaglio","year":"2005","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1002\/hup.2512-BIB0033|hup2512-cit-0033","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.euroneuro.2014.12.012","article-title":"Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones","volume":"25","author":"Rickli","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1002\/hup.2512-BIB0034|hup2512-cit-0034","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/wps.20174","article-title":"Novel psychoactive substances of interest for psychiatry","volume":"14","author":"Schifano","year":"2015","journal-title":"World Psychiatry"},{"key":"10.1002\/hup.2512-BIB0035|hup2512-cit-0035","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/ADM.0000000000000081","article-title":"Combined abuse of clonidine and amitriptyline in a patient on buprenorphine maintenance treatment","volume":"8","author":"Seale","year":"2014","journal-title":"J Addict Med"},{"key":"10.1002\/hup.2512-BIB0036|hup2512-cit-0036","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/jat\/bks047","article-title":"Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry","volume":"36","author":"Shanks","year":"2012","journal-title":"J Anal Toxicol"},{"key":"10.1002\/hup.2512-BIB0037|hup2512-cit-0037","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/hup.2300","article-title":"Novel psychoactive substances as a novel challenge for health professionals: results from an Italian survey","volume":"28","author":"Simonato","year":"2013","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"10.1002\/hup.2512-BIB0038|hup2512-cit-0038","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/hup.1222","article-title":"Longitudinal patterns of benzodiazepine consumption in a German cohort of methadone maintenance treatment patients","volume":"26","author":"Specka","year":"2011","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"10.1002\/hup.2512-BIB0039|hup2512-cit-0039","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/YCO.0000000000000073","article-title":"The new pattern of drug abuse in China","volume":"27","author":"Sun","year":"2014","journal-title":"Curr Opin Psychiatry"},{"key":"10.1002\/hup.2512-BIB0040|hup2512-cit-0040","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1007\/s00216-013-7272-8","article-title":"A high-sensitivity ultra-high performance liquid chromatography\/high-resolution time-of-flight mass spectrometry (UHPLC-HR-TOFMS) method for screening synthetic cannabinoids and other drugs of abuse in urine","volume":"405","author":"Sundstr\u00f6m","year":"2013","journal-title":"Anal Bioanal Chem"},{"key":"10.1002\/hup.2512-BIB0041|hup2512-cit-0041","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/dta.1683","article-title":"Comparison between drug screening by immunoassay and ultra-high performance liquid chromatography\/high-resolution time-of-flight mass spectrometry in post-mortem urine","volume":"7","author":"Sundstr\u00f6m","year":"2015","journal-title":"Drug Test Anal"},{"key":"10.1002\/hup.2512-BIB0042|hup2512-cit-0042","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.1007\/s00216-013-7137-1","article-title":"In silico and in vitro metabolism studies support identification of designer drugs in human urine by liquid chromatography\/quadrupole-time of-flight mass spectrometry","volume":"405","author":"Tyrkk\u00f6","year":"2013","journal-title":"Anal Bional Chem"},{"key":"10.1002\/hup.2512-BIB0043|hup2512-cit-0043","unstructured":"UNODC 2015a Early warning advisory on new psychoactive substances https:\/\/www.unodc.org\/LSS\/Home\/NPS st"},{"key":"10.1002\/hup.2512-BIB0044|hup2512-cit-0044","unstructured":"UNODC 2015b World Drug Report 2015 http:\/\/www.unodc.org\/documents\/wdr2015\/World_Drug_Report_2015.pdf st"},{"key":"10.1002\/hup.2512-BIB0045|hup2512-cit-0045","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1080\/02791072.2014.901587","article-title":"Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention","volume":"46","author":"White","year":"2014","journal-title":"J Psychoactive Drugs"}],"container-title":["Human Psychopharmacology: Clinical and Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhup.2512","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/hup.2512\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T16:06:13Z","timestamp":1718294773000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hup.2512"}},"subtitle":["Polydrug Abuse in Opioid Maintenance Treatment"],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"URL":"https:\/\/doi.org\/10.1002\/hup.2512","archive":["Portico"],"relation":{},"ISSN":["0885-6222"],"issn-type":[{"value":"0885-6222","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}